Insider Selling: Maximus (NYSE:MMS) Insider Sells $173,969.84 in Stock

Maximus, Inc. (NYSE:MMS) insider Michelle Link sold 3,208 shares of the company’s stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $54.23, for a total transaction of $173,969.84. Following the sale, the insider directly owned 13,881 shares in the company, valued at approximately $752,766.63. The trade was a 18.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Maximus Stock Performance

NYSE:MMS opened at $52.72 on Monday. The company has a fifty day simple moving average of $57.31 and a two-hundred day simple moving average of $60.21. The company has a market cap of $2.76 billion, a price-to-earnings ratio of 7.79 and a beta of 0.59. The company has a quick ratio of 2.42, a current ratio of 2.42 and a debt-to-equity ratio of 0.90. Maximus, Inc. has a 52 week low of $51.04 and a 52 week high of $100.00.

Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, August 6th. The health services provider reported $2.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.21 by $0.01. The business had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.33 billion. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The company’s revenue for the quarter was down 5.1% compared to the same quarter last year. During the same period last year, the firm earned $2.16 earnings per share. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. As a group, equities analysts anticipate that Maximus, Inc. will post 8.03 earnings per share for the current fiscal year.

Institutional Trading of Maximus

Several institutional investors and hedge funds have recently made changes to their positions in MMS. Empowered Funds LLC acquired a new position in Maximus during the second quarter worth approximately $504,000. Hsbc Holdings PLC acquired a new stake in shares of Maximus in the second quarter valued at approximately $956,000. Reinhart Partners LLC. boosted its holdings in shares of Maximus by 131.8% in the second quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider’s stock valued at $106,575,000 after acquiring an additional 1,127,346 shares during the period. Corient Private Wealth LP acquired a new position in shares of Maximus in the 2nd quarter valued at $1,984,000. Finally, Assenagon Asset Management S.A. acquired a new position in shares of Maximus in the 2nd quarter valued at $1,719,000. 97.21% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

MMS has been the subject of a number of analyst reports. Zacks Research raised Maximus from a “strong sell” rating to a “hold” rating in a research report on Thursday. Weiss Ratings reiterated a “hold (c-)” rating on shares of Maximus in a research note on Monday, August 17th. Finally, Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, Maximus has an average rating of “Hold”.

About Maximus

Maximus, Inc (NYSE:MMS) is a provider of government services and technology-enabled solutions. The company partners with federal, state, provincial and local governments to administer public programs, improve service delivery and support interactions between governments and the people they serve.

Its business activities include health and human services administration, employment and workforce services, child support and eligibility services, customer contact centers, program management, consulting and digital transformation.